Horizon Diagnostics' Quantitative Multiplex DNA Reference Standard is designed for researchers assessing multiple biomarkers in a single assay, using platforms such as next-generation sequencing (NGS).
The standard enables researchers to quantify a range of detection thresholds
for 11 cancer relevant mutations. This is accomplished across complex
samples in a single assay in the form of renewable material originating from
precisely engineered cell lines. Horizon Diagnostics, a division of Horizon
Discovery Ltd., www.horizondx.com